Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
This study highlights the role of DRGs in LUAD, with a validated gene signature offering new avenues for targeted therapies, potentially improving LUAD treatment outcomes.
Authors
- Tao Shen (ORCID: https://orcid.org/0000-0002-1129-533X)
- Yongwen Ke
- Jie Wu (ORCID: https://orcid.org/0000-0001-6963-0244)
- Zhuming Lu
- Sisi Yang (ORCID: https://orcid.org/0009-0008-2696-9107)
- Weidong Wu
- Dongxi Zhang
- Zhuowen Chen
Institutions
- Jinan University (CN)
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
- Baise University (CN)
- Jiangmen Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-10
- DOI
- https://doi.org/10.3389/fimmu.2025.1540578
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56